News

Nibiru Ventures: Empowering Blockchain Startups for Success

Nibiru Ventures: Empowering Blockchain Startups for Success

Nibiru Ventures: A New Era for Blockchain Innovation

The Nibiru Foundation has proudly launched Nibiru Ventures, a strategic venture arm devoted to enhancing blockchain projects native to the Nibiru ecosystem. This initiative aims to foster the next generation of innovators by providing not just funding, but also essential guidance to bring their pioneering application visions to fruition.

Understanding the Need for Support

Founders often encounter challenges while developing applications, leading to a growing demand for capital and operational support. Many projects targeting multi-chain expansion or focusing on Nibiru face financial hurdles, particularly regarding developer resources and time allocation required for product integration.

“Nibiru Ventures was developed to tackle the obstacles that dApp creators face and to broaden the array of services Nibiru offers, providing initial funding and comprehensive support to expedite their development process,” states Nibiru Chain COO, Jonathan Chang.

Through this innovative program, Nibiru Ventures aspires to lessen the upfront risks associated with launching applications on new chains, ensuring that projects align with Nibiru's vision without compelling them to remain exclusive to the Nibiru ecosystem.

Nibiru Ventures Investment Philosophy

In a landscape rich with ideas, the necessity for applications delivering real value and functionality is paramount. Nibiru Ventures is honing in on consumer-focused applications that generate substantial interest and foster user engagement, as opposed to niche infrastructure projects. The organization prioritizes investments in pre-seed and seed-stage rounds, specifically those promising a quicker route to market.

Key investment areas include groundbreaking decentralized exchanges (DEXs), lending mechanisms, derivatives, and innovative structured product vaults.

“These sectors have shown great potential and align with historical adoption trends and successes observed in Web2, coupled with a strong existing technological framework,” explains Unique Divine, co-founder of Nibiru.

A Spotlight on Significant Investments

One of the hallmark investments from Nibiru Ventures is in LayerBank, a decentralized multi-chain lending platform aimed at establishing itself as a liquidity hub among EVM-compatible Layer 2 and rollup chains. With an impressive total value locked (TVL) exceeding $675 million, LayerBank is on track to launch cross-chain lending functionalities in the near future. This development will unify fragmented liquidity pools across several Layer 2 environments, greatly enhancing the user experience.

If you're interested in the application process for Nibiru Ventures or wish to apply for funding, the application is readily available. Thus, innovative projects gain access to a thoughtfully curated portfolio, as Nibiru Ventures seeks to collaborate with vision-driven founders to invigorate growth in the Web3 landscape.

About Nibiru

Nibiru Chain stands out as a smart contract ecosystem marked by its high-performance, EVM-equivalent execution layer known as Nibiru EVM. Designed to handle the increasing need for adaptable, scalable, and user-friendly Web3 applications, Nibiru has successfully secured an impressive $20.5 million through strategic and seed funding rounds. This venture is backed by noteworthy investors, including NGC Ventures, HashKey Capital, Kraken Ventures, and Tribe Capital.

For any inquiries, feel free to reach out to Nibiru Chain at media@nibiru.org.

Frequently Asked Questions

What is Nibiru Ventures?

Nibiru Ventures is a strategic venture arm launched by the Nibiru Foundation, aimed at supporting blockchain projects within the Nibiru ecosystem.

What types of projects does Nibiru Ventures support?

Nibiru Ventures focuses on consumer-facing applications that drive user engagement, particularly in sectors like DEXs, lending, and derivatives.

How can projects apply for funding from Nibiru Ventures?

Projects can apply through a designated application form available through Nibiru Ventures, allowing them the chance to be part of a curated portfolio.

Who are the notable investors behind Nibiru?

Nibiru has secured funding from prominent investors, including NGC Ventures, HashKey Capital, Kraken Ventures, and Tribe Capital.

What is the total value locked (TVL) in LayerBank?

LayerBank boasts a total value locked (TVL) exceeding $675 million, demonstrating its significant potential in the decentralized finance sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading